{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:10:24Z","timestamp":1789150224319,"version":"build-2803163510"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institutional contracts","award":["PCN\/241\/2020, PCN-1-104\/K\/2\/Z, PCN-2-058\/N\/1\/Z, KNW-1-026\/K\/8\/Z, BNW-1-154\/N\/4\/Z, BNW-2-100\/N\/4\/Z, BNW-2-064\/K\/6\/Z"],"award-info":[{"award-number":["PCN\/241\/2020, PCN-1-104\/K\/2\/Z, PCN-2-058\/N\/1\/Z, KNW-1-026\/K\/8\/Z, BNW-1-154\/N\/4\/Z, BNW-2-100\/N\/4\/Z, BNW-2-064\/K\/6\/Z"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Circulating microRNAs have been proposed as minimally invasive markers of cognitive impairment and neurodegenerative disease, but evidence for individual miRNAs in heterogeneous older populations remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We examined cross-sectional associations between eight circulating serum miRNAs and continuous cognitive performance in a mixed inpatient-outpatient geriatric cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional analysis included 65 enrolled participants from a single-center, non-consecutive, mixed inpatient-outpatient geriatric cohort; 63 formed the analytic cohort (32 inpatients, 31 outpatients). Eligibility required written informed consent, availability of a routine-care Mini-Mental State Examination (MMSE) score, administration of Addenbrooke\u2019s Cognitive Examination III (ACE-III), fasting serum sampling, and structural brain MRI during the same visit or within 48 hours. Eight predefined serum miRNAs were quantified by RT-qPCR with exogenous spike-in controls, with cel-miR-39-3p used as the normalization reference. The primary outcome was continuous MMSE score. Secondary outcomes were ACE-III total score, the ACE-III attention\/orientation subscale, and threshold-defined MMSE and ACE-III impairment categories. Multivariable linear or logistic regression models were adjusted for age, sex, years of education, and recruitment setting. The main analysis used adjusted linear regression for continuous MMSE with Benjamini-Hochberg false discovery rate correction across the eight individual-miRNA MMSE models. Bootstrap was used to assess the stability of the MMSE estimates. Sensitivity analyses for the three strongest MMSE associations included Huber robust regression and miRNA by setting interaction testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In multivariable models adjusted for age, sex, years of education, and recruitment setting, higher levels of miR-132, miR-545, and miR-34a were linked to lower MMSE scores. A 1-SD increase in each marker corresponded to an MMSE decrease of about 1.1\u20131.3 points. These were the strongest single-miRNA findings in the dataset and met the prespecified FDR threshold in the primary models, although bootstrap analyses showed limited precision. Robust regression gave the same negative pattern for all three markers, suggesting that the results were not driven by a small number of extreme observations. Evidence of between-setting differences was seen only for miR-132 and only at the nominal level. No individual miRNA showed a clear nominal association with ACE-III total, and the ACE-III attention\/orientation and MRI-adjusted analyses were exploratory. In secondary threshold-based models, no single miRNA remained significant after FDR correction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this cross-sectional pilot cohort, higher miR-132, miR-545, and miR-34a were associated with lower MMSE scores in adjusted analyses. However, effect sizes were small, bootstrap analysis showed considerable uncertainty, and the findings are exploratory and hypothesis-generating. These results require evaluation in larger consecutive cohorts and do not establish diagnostic, prognostic, or standalone clinical biomarker utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0357295","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:41:03Z","timestamp":1789148463000},"page":"e0357295","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Individual circulating microRNAs and continuous cognitive performance in a mixed inpatient-outpatient geriatric cohort: A cross-sectional pilot study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4426-2227","authenticated-orcid":true,"given":"Krzysztof","family":"Wilczy\u0144ski","sequence":"first","affiliation":[{"name":"Medical University of Silesia","place":["Katowice, Poland"],"department":["Department of Geriatrics, School of Health Sciences in Katowice"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Garczorz","sequence":"additional","affiliation":[{"name":"Medical University of Silesia","place":["Katowice, Poland"],"department":["Department of Biochemistry, School of Medicine in Katowice"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kosowska","sequence":"additional","affiliation":[{"name":"Medical University of Silesia","place":["Katowice, Poland"],"department":["Department of Biochemistry, School of Medicine in Katowice"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Francuz","sequence":"additional","affiliation":[{"name":"Medical University of Silesia","place":["Katowice, Poland"],"department":["Department of Biochemistry, School of Medicine in Katowice"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Antoniak-Sobczak","sequence":"additional","affiliation":[{"name":"Medical University of Silesia","place":["Katowice, Poland"],"department":["Department of Geriatrics, School of Health Sciences in Katowice"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1438-5813","authenticated-orcid":true,"given":"Joanna","family":"Dudzi\u0144ska-Griszek","sequence":"additional","affiliation":[{"name":"Medical University of Silesia","place":["Katowice, Poland"],"department":["Department of Geriatrics, School of Health Sciences in Katowice"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Batko-Szwaczka","sequence":"additional","affiliation":[{"name":"Medical University of Silesia","place":["Katowice, Poland"],"department":["Department of Geriatrics, School of Health Sciences in Katowice"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Szewieczek","sequence":"additional","affiliation":[{"name":"Medical University of Silesia","place":["Katowice, Poland"],"department":["Department of Geriatrics, School of Health Sciences in Katowice"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"6","key":"pone.0357295.ref001","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14333","article-title":"Alzheimer\u2019s Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer\u2019s Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care","volume":"21","author":"A Atri","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"4","key":"pone.0357295.ref002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"CR Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"1","key":"pone.0357295.ref003","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114408","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease","volume":"14","author":"A Leuzy","year":"2022","journal-title":"EMBO Mol Med"},{"key":"pone.0357295.ref004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan microRNAs","volume":"173","author":"DP Bartel","year":"2018","journal-title":"Cell"},{"issue":"30","key":"pone.0357295.ref005","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"PS Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"pone.0357295.ref006","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","article-title":"Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)","volume":"50","author":"EM Kroh","year":"2010","journal-title":"Methods"},{"issue":"6","key":"pone.0357295.ref007","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jmoldx.2013.07.005","article-title":"Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability","volume":"15","author":"IS Sourvinou","year":"2013","journal-title":"J Mol Diagn"},{"issue":"4","key":"pone.0357295.ref008","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"SA Bustin","year":"2009","journal-title":"Clin Chem"},{"issue":"9","key":"pone.0357295.ref009","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1007\/s12035-019-1500-y","article-title":"Systematic review of miRNA as biomarkers in Alzheimer\u2019s disease","volume":"56","author":"S Swarbrick","year":"2019","journal-title":"Mol Neurobiol"},{"key":"pone.0357295.ref010","doi-asserted-by":"crossref","first-page":"1231486","DOI":"10.3389\/fgene.2023.1231486","article-title":"A new perspective on Alzheimer\u2019s disease: microRNAs and circular RNAs","volume":"14","author":"SZ Abidin","year":"2023","journal-title":"Front Genet"},{"issue":"2","key":"pone.0357295.ref011","doi-asserted-by":"crossref","first-page":"020501","DOI":"10.11613\/BM.2024.020501","article-title":"Preanalytical, analytical and postanalytical considerations in circulating microRNAs measurement","volume":"34","author":"M Zendjabil","year":"2024","journal-title":"Biochem Med (Zagreb)"},{"issue":"1","key":"pone.0357295.ref012","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41398-024-03075-8","article-title":"MicroRNAs: pioneering regulators in Alzheimer\u2019s disease pathogenesis, diagnosis, and therapy","volume":"14","author":"Y-B Li","year":"2024","journal-title":"Transl Psychiatry"},{"issue":"23","key":"pone.0357295.ref013","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1093\/hmg\/ddv377","article-title":"miR-132\/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo","volume":"24","author":"PY Smith","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"5","key":"pone.0357295.ref014","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","article-title":"Transcriptional activation of miR-34a contributes to p53-mediated apoptosis","volume":"26","author":"N Raver-Shapira","year":"2007","journal-title":"Mol Cell"},{"key":"pone.0357295.ref015","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1007\/s12035-016-0088-8","article-title":"Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer\u2019s disease: potential and limitations.","volume":"54","author":"M Cosin-Tomas","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"2","key":"pone.0357295.ref016","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-130932","article-title":"MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer\u2019s disease","volume":"39","author":"T Kiko","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"pone.0357295.ref017","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41398-022-01806-3","article-title":"Brain microRNAs are associated with variation in cognitive trajectory in advanced age","volume":"12","author":"AP Wingo","year":"2022","journal-title":"Transl Psychiatry"},{"key":"pone.0357295.ref018","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3389\/fnins.2019.01208","article-title":"miR-212 and miR-132 are downregulated in neurally derived plasma exosomes of Alzheimer\u2019s patients","volume":"13","author":"DJ Cha","year":"2019","journal-title":"Front Neurosci"},{"key":"pone.0357295.ref019","doi-asserted-by":"crossref","first-page":"112063","DOI":"10.1016\/j.mad.2025.112063","article-title":"miR-132-3p is down-regulated in plasma and CD171+ extracellular vesicles isolated from patients with mild Alzheimer\u2019s disease","volume":"225","author":"M Sbriscia","year":"2025","journal-title":"Mech Ageing Dev"},{"key":"pone.0357295.ref020","doi-asserted-by":"crossref","first-page":"146327","DOI":"10.1016\/j.brainres.2019.146327","article-title":"Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer\u2019s disease-like pathology","volume":"1721","author":"S Sarkar","year":"2019","journal-title":"Brain Res"},{"issue":"15","key":"pone.0357295.ref021","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.15252\/embj.201387576","article-title":"MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer\u2019s disease","volume":"33","author":"J Banzhaf-Strathmann","year":"2014","journal-title":"EMBO J"},{"key":"pone.0357295.ref022","first-page":"21","article-title":"Serum exosomal miRNA-125b and miRNA-451a are potential diagnostic biomarker for Alzheimer\u2019s diseases","volume":"14","author":"X Duan","year":"2024","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"pone.0357295.ref023","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neurobiolaging.2019.06.005","article-title":"miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer\u2019s disease","volume":"82","author":"A Ansari","year":"2019","journal-title":"Neurobiol Aging"},{"key":"pone.0357295.ref024","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fnagi.2019.00366","article-title":"miR-146a plasma levels are not altered in Alzheimer\u2019s disease but correlate with age and illness severity","volume":"11","author":"E Maffioletti","year":"2020","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"pone.0357295.ref025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13195-019-0501-4","article-title":"Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer\u2019s disease","volume":"11","author":"D Siedlecki-Wullich","year":"2019","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"pone.0357295.ref026","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13748","article-title":"Exosomal miR-532-5p induced by long-term exercise rescues blood-brain barrier function in 5XFAD mice via downregulation of EPHA4","volume":"22","author":"X Liang","year":"2023","journal-title":"Aging Cell"},{"issue":"5","key":"pone.0357295.ref027","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.4103\/NRR.NRR-D-23-01566","article-title":"The complex effects of miR-146a in the pathogenesis of Alzheimer\u2019s disease","volume":"20","author":"Y Long","year":"2025","journal-title":"Neural Regen Res"},{"key":"pone.0357295.ref028","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3233\/JAD-142847","article-title":"Serum miR-206 and miR-132 as potential circulating biomarkers for mild cognitive impairment","volume":"45","author":"B Xie","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"pone.0357295.ref029","doi-asserted-by":"crossref","first-page":"111961","DOI":"10.1016\/j.exger.2022.111961","article-title":"Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population","volume":"169","author":"NZ Abuelezz","year":"2022","journal-title":"Exp Gerontol"},{"issue":"11","key":"pone.0357295.ref030","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1002\/alz.14230","article-title":"Plasma miRNAs across the Alzheimer\u2019s disease continuum: relationship to central biomarkers","volume":"20","author":"S Liu","year":"2024","journal-title":"Alzheimers Dement"},{"key":"pone.0357295.ref031","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000351671","article-title":"Validation of the Addenbrooke\u2019s Cognitive Examination III in frontotemporal dementia and Alzheimer\u2019s disease","volume":"36","author":"S Hsieh","year":"2013","journal-title":"Dement Geriatr Cogn Disord"},{"key":"pone.0357295.ref032","doi-asserted-by":"crossref","first-page":"12257","DOI":"10.3390\/ijerph191912257","article-title":"Applying ACE-III, M-ACE and MMSE to diagnostic screening assessment of cognitive functions within the Polish population","volume":"19","author":"B Kaczmarek","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"pone.0357295.ref033","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41598-024-52681-5","article-title":"Analysis of the longitudinal stability of human plasma miRNAs and implications for disease biomarkers","volume":"14","author":"US Sandau","year":"2024","journal-title":"Sci Rep"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:41:09Z","timestamp":1789148469000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357295"}},"subtitle":[],"editor":[{"given":"Stephen D.","family":"Ginsberg","sequence":"first","affiliation":[{"name":"Nathan S Kline Institute","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0357295","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}